Kersti O.
- Country
- Estonia
- Department
- Oncology and Haematology Clinic
Research Overview
- Phase III Trial of BI 764532 Plus Atezolizumab, Carboplatin, and Etoposide as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
- Evaluation of Thoracic Radiotherapy Combined with Durvalumab and Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase III Trial
- Phase 3 Evaluation of Pembrolizumab and Olaparib with Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 158 of 377 partner sites.
Specializations
Renal and Urological Conditions
The investigator specializes in treating complicated urinary tract infections and acute pyelonephritis. Their expertise extends to Immunoglobulin A Nephropathy, focusing on innovative therapeutic approaches for kidney preservation and proteinuria reduction.
- Urinary Tract Infections
- Renal Function Preservation
- IgA Nephropathy Management
Cardiovascular Medicine
This clinician focuses on treating atrial fibrillation and acute coronary syndrome. Their work encompasses prevention of cardioembolic events and management of post-heart attack complications.
- Stroke Prevention
- Cardiovascular Event Management
- Systemic Embolism Prevention
Autoimmune Conditions
The investigator has extensive experience in treating multiple autoimmune conditions, including Type 1 diabetes mellitus, psoriatic arthritis, and Crohn's disease. Their work focuses on innovative therapeutic approaches for these chronic conditions.
- Beta Cell Function Preservation
- Inflammatory Arthritis Management
- Gastrointestinal Inflammation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.